Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. (8th September 2022) - Ishida, Tadao; Ito, Shigeki; Tanaka, Junji; Uchiyama, Michihiro; Kawano, Yawara; Moreau, Philippe; Martin, Thomas; Risse, Marie-Laure; Tada, Keisuke; Suzuki, Kenshi; Ishizawa, Kenichi